Pediatric myelofibrosis: WHO 2024 update on myeloproliferative neoplasms calling?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pediatric myelofibrosis: WHO 2024 update on myeloproliferative neoplasms calling?

Published:2020-05 Issue:5 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mishra Priyanka¹,Halder Rohan¹^ORCID,Aggarwal Mukul¹,Seth Tulika¹,Mahapatra Manoranjan¹,Pati Hara Prasad¹,Saxena Renu¹,Tyagi Seema¹

Affiliation:

1. Department of HematologyAll India Institute of Medical Sciences (AIIMS) New Delhi India

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28232

Reference12 articles.

1. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

2. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

3. Clinical, histopathologic, and genetic features of pediatric primary myelofibrosis-An entity different from adults

4. CALR mutation screening in pediatric primary myelofibrosis

5. European consensus on grading bone marrow fibrosis and assessment of cellularity;Thiele J;Haematologica,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of remission after donor lymphocyte infusion following allogeneic transplant in a case of pediatric primary myelofibrosis;Pediatric Blood & Cancer;2024-08-04

2. Myeloproliferative Neoplasms (MPNs);Pediatric Pathology of Hematopoietic and Histiocytic Disorders;2024-02-15

3. Pediatric autoimmune myelofibrosis: Experience from a large pediatric tertiary care center;Pediatric Blood & Cancer;2023-01-20

4. Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity;Frontiers in Pediatrics;2022-11-07

5. Pediatric myelofibrosis due to compound heterozygous MPIG6B mutations in a patient of European ancestry;Pediatric Blood & Cancer;2022-10-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3